No connection

Search Results

XXII

BEARISH
$1.71 Live
22nd Century Group, Inc. · NASDAQ
Target $135.0 (+7794.7%)
$1.61 52W Range $489.9

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 24, 2026
Market cap
$1.23M
P/E
N/A
ROE
-116.6%
Profit margin
-71.7%
Debt/Equity
0.08
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
XXII is in a state of severe financial distress, evidenced by a critical Piotroski F-Score of 1/9. The company is experiencing a catastrophic collapse in valuation, with a 1-year price decline of 99.4% and negative gross margins of -44.50%, meaning it loses money on every unit sold. While the current ratio of 2.42 suggests short-term liquidity, the operational burn and 43% YoY revenue decline indicate a failing business model. The disconnect between the current price ($1.71) and the lone analyst's target ($135.00) suggests the target is obsolete and not reflective of current fundamentals.

Key Strengths

Low Debt/Equity ratio (0.08)
Current Ratio of 2.42 provides a temporary liquidity buffer
Extremely low Price-to-Book ratio (0.06)
Low Price-to-Sales ratio (0.17)
Minimal long-term debt burden

Key Risks

Negative Gross Margins (-44.50%) indicate an unsustainable product offering
Severe revenue contraction (-43.10% YoY)
Extreme price depreciation (-100% over 3-5 years)
Consistent and massive earnings misses over multiple quarters
Operating margins are deeply negative (-253.15%)
AI Fair Value Estimate
Based on comprehensive analysis
$0.5
-70.8% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
8
Weak
Value
20
Future
5
Past
0
Health
15
Dividend
0
AI Verdict
Critical Distress
Key drivers: Piotroski F-Score 1/9, Negative Gross Margins, Collapsing Revenue, Total Price Collapse
Confidence
95%
Value
20/100

P/E is N/A due to losses; P/B is low but reflects impaired asset value.

Positives
  • P/B of 0.06 is nominally very cheap
Watchpoints
  • Classic value trap
  • No earnings to support a Graham Number
  • Negative ROE
Future
5/100

Growth rates are sharply negative across both YoY and Q/Q metrics.

Positives
No standout positives identified.
Watchpoints
  • Revenue growth is -43.10%
  • Operating margins are deeply negative
  • No clear path to profitability
Past
0/100

Historical price performance shows a total loss of shareholder value.

Positives
No standout positives identified.
Watchpoints
  • 5-year price change is -100%
  • Consistent history of earnings misses
  • Long-term trend is purely bearish
Health
15/100

Piotroski F-Score indicates the company is in the weakest possible health bracket.

Positives
  • Low Debt/Equity
  • Positive Current Ratio
Watchpoints
  • Piotroski F-Score of 1/9
  • Negative ROA and ROE
  • Severe operational losses
Dividend
0/100

Dividend yield is N/A.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • No capacity to pay dividends

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.71
Analyst Target
$135.0
Upside/Downside
+7794.7%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for XXII and closest competitors.

Updated 2026-04-23
XXI
22nd Century Group, Inc.
Primary
5Y
-100.0%
3Y
-100.0%
1Y
-99.4%
6M
-92.5%
1M
-50.1%
1W
-17.0%
GV
Visionary Holdings Inc.
Peer
5Y
-99.9%
3Y
-98.0%
1Y
-84.7%
6M
-81.8%
1M
-49.4%
1W
-37.6%
PAV
Paranovus Entertainment Technology Ltd.
Peer
5Y
-100.0%
3Y
-100.0%
1Y
-99.9%
6M
-99.8%
1M
-56.5%
1W
-12.6%
GNL
Greenlane Holdings, Inc.
Peer
5Y
-100.0%
3Y
-100.0%
1Y
-99.8%
6M
-91.2%
1M
-58.4%
1W
+2.9%
IBG
Innovation Beverage Group Limited
Peer
5Y
-98.5%
3Y
-98.5%
1Y
-93.3%
6M
-92.9%
1M
-53.1%
1W
-7.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-0.11
PEG Ratio
N/A
P/B Ratio
0.06
P/S Ratio
0.17
EV/Revenue
-0.26
EV/EBITDA
0.17
Market Cap
$1.23M

Profitability

Profit margins and return metrics

Profit Margin -71.7%
Operating Margin -253.15%
Gross Margin -44.5%
ROE -116.58%
ROA -29.3%

Growth

Revenue and earnings growth rates

Revenue Growth -43.1%
Earnings Growth N/A
Q/Q Revenue Growth -43.07%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.08
Low debt
Current Ratio
2.42
Strong
Quick Ratio
1.48
Good
Cash/Share
$10.8

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
-79.6%
Op. Margin
-253.1%
Net Margin
-267.9%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.71x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
73%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-15
$N/A
2026-03-26
$-5.89
-180.5% surprise
2024-05-15
$-136930.45
+44.3% surprise
2024-03-28
$-856979.66
-79.7% surprise

Consumer Defensive Sector Comparison

Comparing XXII against 138 companies in the Consumer Defensive sector (8 bullish, 51 neutral, 79 bearish)
Return on Equity (ROE)
-116.58%
This Stock
vs
-22.18%
Sector Avg
+425.5% (Excellent)
Profit Margin
-71.7%
This Stock
vs
-8.73%
Sector Avg
+721.7% (Superior)
Debt to Equity
0.08
This Stock
vs
1.39
Sector Avg
-94.2% (Less Debt)
Revenue Growth
-43.1%
This Stock
vs
135.98%
Sector Avg
-131.7% (Slower)
Current Ratio
2.42
This Stock
vs
2.51
Sector Avg
-3.4% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KEYS DAVID N
Director
Stock Award
2025-11-10
12,578 shares
SALHANY LUCILLE S
Director
Stock Award
2025-11-10
11,006 shares
FIRESTONE LAWRENCE D.
Chief Executive Officer
Stock Award
2025-11-10
66,824 shares
ARNO ANDREW
Director
Stock Award
2025-11-10
17,295 shares
MANFREDONIA ROBERT P
Officer
Stock Award
2025-11-10
32,429 shares
OTTO DANIEL A
Chief Financial Officer
Stock Award
2025-11-10
37,146 shares
STAFFELDT JONATHAN
Officer
Stock Award
2025-11-10
37,146 shares
MARION ARVIL S
Officer
Stock Award
2025-11-10
32,429 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-K
10-K
2026-03-26

XXII filed its annual 10-K report on March 26, 2026, which includes sections on business operations, risk factors, and management's discussion and analysis. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
8-K
2026-03-26
8-K
8-K
2026-03-20
8-K
8-K
2026-02-20

XXII filed an 8-K on February 20, 2026, likely to announce its annual financial results.

8-K
8-K
2026-01-22

XXII filed a current report on January 22, 2026, likely announcing its fourth quarter and full-year financial results.

DEF 14A
DEF 14A
2025-12-30

XXII filed a Definitive Proxy Statement on December 30, 2025, providing shareholders with information regarding matters to be voted on at an upcoming meeting.

8-K
8-K
2025-12-17
10-Q
10-Q
2025-11-04

XXII filed its quarterly 10-Q report on November 4, 2025. The filing includes a section on risk factors under Item 1A, although specific financial highlights and detailed risk descriptions were not provided in the available excerpt.

8-K
8-K
2025-11-04

XXII filed a current report on November 4, 2025, likely announcing its third-quarter financial results.

8-K
8-K
2025-09-24
8-K
8-K
2025-09-18
8-K
8-K
2025-08-26
8-K
8-K
2025-08-25
8-K
8-K
2025-08-14
10-Q
10-Q
2025-08-14
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning XXII from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile